(Press-News.org) CHICAGO – A study that examined the relationship between two cerebrospinal fluid proteins associated with Alzheimer disease in clinically and cognitively normal older patients suggests that amyloid-β (Αβ)-associated clinical decline was linked to the presence of elevated phospho-tau (p-tau), according to a report published Online First by Archives of Neurology, a JAMA Network publication.
Identifying clinically normal older individuals destined to develop Alzheimer disease (AD) is increasingly important as therapeutic interventions to prevent dementia are developed, the authors write in their study background.
Rahul S. Desikan, M.D., Ph.D., of the University of California-San Diego School of Medicine, and colleagues evaluated 107 healthy individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI). They examined the relationship of cerebrospinal fluid (CSF) levels of phospho-tau 181 (p-tau 181p ) and CSF Αβ 1-42 with clinical decline using, among other measures, the global Clinical Dementia Rating (CDR) scale and the Alzheimer Disease Assessment Scale-cognitive subscale.
The results indicate a "significant relationship" between decreased CSF Αβ 1-42 and change in those assessment measures in participants with elevated CSF p-tau 181p .
"These findings provide important insights into the preclinical stage of AD," the authors comment. "Consistent with prior studies, our results indicate that in clinically normal older individuals, Αβ deposition by itself is not associated with clinical decline; the presence of p-tau represents a critical link between Αβ deposition and accelerated clinical decline. Furthermore, our findings point to p-tau as an important marker of AD-associated degeneration."
The authors note that while their findings indicate that CSF Αβ 1-42 in combination with CSF p-tau 181p "may better predict clinical decline" than CSF Αβ 1-42 in combination with CSF t-tau, prior studies have shown that CSF p-tau and t-tau when combined with CSF Αβ 1-42 are "equally predictive of decline."
Researchers note that early intervention trials should consider both the CSF p-tau 181p and CSF Αβ 1-42 status of participants and the authors suggest their findings highlight the need to develop therapies that specifically target tau.
"It is feasible that although Αβ initiates the degenerative cascade, elevated levels of tau may represent a second phase of the AD pathologic process where neurodegenerative changes occur largely independent of Αβ," the authors conclude.
(Arch Neurol. Published online April 23, 2012. doi:10.1001/archneurol.2011.3354. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: Several authors made financial disclosures. The study was supported by grants from the National Institutes of Health and a Young Scholar Award from the Alzheimer's Association San Diego/Imperial Chapter. Data collection and sharing for this study were funded by the Alzheimer's Disease Neuroimaging Initiative. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Cerebrospinal Fluid Biomarkers for Secondary Prevention Trial
In an editorial, David M. Holtzman, M.D., of Washington University, St. Louis, writes: "If both academic groups and the pharmaceutical industry are going to move toward prevention trials to delay the onset of cognitive impairment and dementia, biomarkers will need to be used to select people who are clinically normal but at high risk for near-term cognitive decline. Without such an approach, trial size will be enormous and cost prohibitive, and individuals may be subjected to treatments that have the potential for toxicity with no clear benefit."
"Results from this new study, as well as previous studies with similar findings, strongly suggest that in otherwise health individuals aged 55 to 85 years, use of these CSF biomarkers may allow for selection of approximately 20 percent of such a population that meet the criteria for the presence of amyloid deposition and neurodegeneration to select for a secondary prevention trial that could be completed with a clinical and cognitive readout during a 3-year period," Holtzman continues.
"The ultimate goal in treating any disease is to delay or prevent its occurrence. With the looming epidemic of AD, we are now at the point where we can and need to design rational trials to delay or prevent dementia," he concludes.
###
(Arch Neurol. Published online April 23, 2012. doi:10.1001/archneurol.2012.587. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: The author is on scientific advisory boards and has consulted. His laboratory receives research grants from the National Institutes of Health, Cure Alzheimer Fund, Ellison Medical Foundation, Eli Lilly, AstraZeneca, Pfizer, Integrated Diagnostics and C2N Diagnostics. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact author Rahul S. Desikan, M.D., Ph.D., call Scott LaFee at 619-543-6163 or email slafee@ucsd.edu. To contact editorial author David M. Holtzman, M.D., call Diane Duke Williams at 314-286-0111 or email williamsdia@wustl.edu.
END
CHICAGO – An analysis of individual data from prospective studies assessing the risks of thyroid dysfunction suggests that subclinical hyperthyroidism may be associated with increased risk of total mortality, coronary heart disease (CHD) death and incident atrial fibrillation (AF), although the risk of CHD mortality and AF is higher when thyrotropin levels are below 0.10 mIU/L, according to a report published Online First in Archives of Internal Medicine, a JAMA Network publication.
Subclinical hyperthyroidism is defined by low thyrotropin levels with normal concentrations ...
CHICAGO – Treatment of subclinical hypothyroidism with the medication levothyroxine appears to be related to fewer ischemic heart disease events in younger patients but this finding was not evident in older patients, according to a report published Online First in Archives of Internal Medicine, a JAMA Network publication.
Subclinical hypothyroidism (SCH) is defined as an elevated serum thyrotropin level in the presence of normal thyroid hormone concentrations. The condition is relatively common and often asymptomatic, although recent meta-analyses have suggested that ...
Slotland has had two major jackpot winners in the last few weeks. Since there'd just been a massive $180,000 jackpot win, last week's $68K winner was hardly expecting Slotland's progressive jackpot to pay out again so soon.
"On average, we've always gone six to eight weeks between big jackpot winners," said Slotland manager Michael Hilary. "None of us, least of all the winner, thought there'd be another jackpot win already!"
First Alice M, known as SCRAPPIER at Slotland, won the progressive jackpot at $180,717. It was re-set to $50,000 and just ...
Scientists have discovered multiple gene switches in Salmonella that offer new ways to curb human infection. The discovery of the mechanisms of gene regulation could lead to the development of antibiotics to reduce the levels of disease caused by Salmonella. The breakthrough was made by Professor Jay Hinton, Stokes Professor of Microbial Pathogenesis, Trinity College Dublin and his research team* and has just been published in the leading journal Proceedings of the National Academy of Sciences (PNAS). Science Foundation Ireland funded the research.
Salmonella causes ...
Since the 1930s, there have been 75 documented episodes of malaria resurgence worldwide, most of which were linked to weakening of malaria control programs, finds a new study published in BioMed Central's open access journal Malaria Journal. The study, which is allied to the theme of this year's World Malaria Day (25th April 2012) "Sustain Gains, Save Lives: Invest in Malaria", found that the most common reason for weakening of malaria control programs was funding disruptions.
There are over 200 million cases of malaria each year with 85% of all cases being children ...
Seattle, April 24, 2012— Rotavirus vaccines offer the best hope for preventing severe rotavirus disease and the deadly dehydrating diarrhea that it causes, particularly in low-resource settings where treatment for rotavirus infection is limited or unavailable, according to studies published in the April 2012 special supplement to the journal Vaccine. The special supplement, "Rotavirus Vaccines for Children in Developing Countries," summarizes data on the performance of rotavirus vaccines to help maximize their impact in developing countries and adds to the growing body ...
History Associates Incorporated has been contracted by The U.S. Maritime Administration to inventory and catalog all if its heritage assets at the campus of the United States Merchant Marine Academy (USMMA) in Kings Point, NY.
"The merchant marine is an important part of our country's heritage," noted History Associates president Brian Martin. "We are honored to be selected to help capture and preserve this important legacy for the benefit of the public, the academy, and generations to come."
Professional collections managers from History Associates ...
Lake Bonney in Antarctica is perennially covered in ice. It is exposed to severe environmental stresses, including minimal nutrients, low temperatures, extreme shade, and, during the winter, 24-hour darkness. But, for the single-celled organisms that live there, the lake is home. To study them, Dr. Rachel Morgan-Kiss from the University of Miami, Ohio, and her team went to Antarctica to sample the ice-covered lake. The article describing her method will be published April 20, in the JoVE (the Journal of Visualized Experiments).
"Our laboratory has a focus on understanding ...
For 300 million years, they were the ultimate survivors. They successfully negotiated three mass extinctions, only to die out eventually at the end of the Cretaceous along with the dinosaurs: Ammonoids, or ammonites as they are also known, were marine cephalopods believed to be related to today's squid and nautiloids. Ammonoids changed their reproductive strategy early on in the course of evolution. However, what was once a successful initial strategy may well have proved to be a fatal boomerang at the end of the Cretaceous, as an international team of researchers headed ...
Just as banks store away only the most valuable possessions in the most secure safes, cells prioritise which genes they guard most closely, researchers at the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) have found. The study, published online today in Nature, shows that bacteria have evolved a mechanism that protects important genes from random mutation, effectively reducing the risk of self-destruction. The findings answer a question that has been under debate for half a century and provide insights into how disease-causing mutations ...
